freemexy's blog

New data from an extension study of the PHIRST trial indicate that patients with pulmonary arterial hypertension continued to benefit from treatment with tadalafil after an additional 52 weeks of therapy.Tadalafil powder half life

Results from the previously published, multicenter, randomized, placebo-controlled, 16-week Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) study linked treatment with tadalafil 40 mg (Adcirca, Lilly) — the highest of four doses evaluated — to significantly improved 6-minute walk distance, time to clinical worsening and quality of life.

To evaluate the long-term safety and durability of efficacy of tadalafil in patients with pulmonary arterial hypertension, researchers conducted PHIRST-2 — a double blind, uncontrolled extension study in which patients were randomly assigned to receive once-daily tadalafil 20 mg (n=63) or 40 mg (n=294) for an additional 52 weeks.

Patients who received tadalafil 20 mg or 40 mg in both PHIRST and PHIRST-2 maintained improvements in 6-minute walk distances achieved during PHIRST (406 m and 413 m, respectively) at the conclusion of the extension study (415 m and 410 m, respectively). Those previously receiving lower doses or placebo during PHIRST, however, did not experience a similar level of improvement.

A higher proportion of patients receiving tadalafil 20 mg experienced WHO functional class deterioration when compared with those assigned tadalafil 40 mg (9% vs. 6.

Post-hoc analyses associated background bosentan (Tracleer, Actelion) use and higher 6-minute walk distance at PHIRST baseline with fewer clinical worsening events.

Safety profiles from both PHIRST and PHIRST-2 were comparable, according to the study results. Ninety-two percent of patients experienced at least one treatment-emergent adverse event during PHIRST-2, 49% of which may have been drug-related. Most adverse events, however, were mild to moderate in intensity and did not result in study discontinuation.

“These data demonstrate that the long-term safety profile of tadalafil appears similar to that in the 16-week PHIRST study and that treatment for up to 68 weeks appears safe and well tolerated,” the researchers wrote. “For patients receiving [tadalafil 20 mg] or [tadalafil 40 mg], the short-term improvements in exercise capacity observed in PHIRST appeared to be maintained for an additional 52 weeks in PHIRST-2.”

Eli Lilly and Company (NYSE: LLY) announced today that study results published in the Journal of Sexual Medicine showed a greater percentage of men who had an incomplete response to as-needed PDE5 inhibitor treatment returned to normal erectile function when given Cialis once daily, compared to placebo, as measured by the erectile function domain of the International Index of Erectile Function (IIEF-EF). In a pre-specified secondary measure, Cialis significantly improved erectile function scores versus placebo in those men who had an incomplete response to as-needed PDE5 treatment.buyaas Tadalafil

Cialis is a phosphodiesterase type 5 inhibitor approved by the Food and Drug Administration (FDA) for erectile dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia (BPH) and both ED and the signs and symptoms of BPH (ED+BPH).

"PDE5 inhibitors are highly effective for most men when taken as-needed, but responses can range from minimal change to a return to normal erectile function," said Dr. Edward D. Kim, MD, of the Division of Urology, Department of Surgery, University of Tennessee Graduate School of Medicine and lead author of the study. "We believe the study outcome will help prescribers make better informed decisions when treating their patients."

It is important to note that Cialis is not to be taken with medicines called "nitrates" such as isosorbide dinitrate or isosorbide mononitrate which are often prescribed for chest pain; or with recreational drugs called "poppers" like amyl or butyl nitrite, as the combination may cause an unsafe drop in blood pressure; or if allergic to Cialis or Adcirca® (tadalafil), or any of its ingredients. Anyone who experiences any symptoms of an allergic reaction, such as rash, hives, swelling of the lips, tongue or throat, or difficulty breathing or swallowing, should call a healthcare provider or get help right away.
The randomized, double-blind, parallel, placebo-controlled trial was conducted in 51 sites in the United States and Canada. The study enrolled men with ED aged 18 years and older who had some response (IIEF-EF > /= 17) but were unable to reach normal erectile function (IIEF-EF < 26) while on a maximum dose of an as-needed PDE5 inhibitor treatment. The study assessed whether Cialis for once daily use is superior to placebo in returning these men to normal erectile function. A total of 623 subjects were randomly assigned to receive treatment with Cialis for once daily use or placebo.

The primary objective was to determine whether a significantly greater percentage of incomplete responders had a return to normal erectile function when treated with tadalafil 2.5 titrated to 5 mg and 5 mg once daily compared to placebo. The key secondary objective was evaluation of the efficacy of tadalafil 2.5 titrated to 5 mg and 5 mg once daily compared to placebo, as measured by change from baseline to endpoint in IIEF-EF.

The International Index of Erectile Function-Erectile Function Domain (IIEF-EF) is a questionnaire evaluating sexual function where higher scores indicate better erectile function.

Product name: Tadalafil
Key words: Tadalafil , anabolic, bodybuilding, steroid powder
Chemical Formula: C22H19N3O4
Molecular Weight: 389.341
CAS No: 171596-29-5
Packing: Foil bag
Quality standard: USP31/BP2005
White Crystalline Powder
Storage: Shading, Confined Preservation
Usage: Can be used as pharmaceutical material. Its main function is to promote metabolism.
Anabolic effects include growth of muscle mass and strength, increased bone density and strength, and stimulation of linear growth and bone maturation.
Delivery: Express courier.Tadalafil powder dosage

Tadalafil relaxes muscles of the blood vessels and increases blood flow to particular areas of the body.Tadalafil under the name of Cialis is used to treat erectile dysfunction (impotence) and symptoms of benign prostatic hypertrophy (enlarged prostate). Another brand of tadalafil is Adcirca, which is used to treat pulmonary arterial hypertension and improve exercise capacity in men and women.
Application

Tadalafil (Cialis) is used to treat erectile dysfunction (ED, impotence; inability to get or keep an erection), and the symptoms of benign prostatic hyperplasia (BPH; an enlarged prostate) which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency in adult men. Tadalafil (Adcirca) is used to improve the ability to exercise in people with pulmonary arterial hypertension (PAH; high blood pressure in the vessels carrying blood to the lungs, causing shortness of breath, dizziness, and tiredness). Tadalafil is in a class of medications called phosphodiesterase (PDE) inhibitors. It works to treat erectile dysfunction by increasing blood flow to the penis during sexual stimulation. This increased blood flow can cause an erection. Tadalafil treats PAH by relaxing the blood vessels in the lungs to allow blood to flow more easily.
Dosage

For most individuals, the recommended starting dose of tadalafil is 10 mg per day taken before sexual activity (tadalafil for use as needed). Depending on the adequacy of the response or side effects, the dose may be increased to 20 mg or decreased to 5 mg a day. The effect of tadalafil may last up to 36 hours. Individuals who are taking medications that increase the blood levels of tadalafil should not exceed a total dose of 10 mg in 72 hours (See drug interactions). For once daily use without regard to sexual activity the recommended dose is 2.5 to 5 mg daily. Tadalafil should not be taken more than once daily.

The recommended dose for BPH, or BPH and ED is 5 mg daily taken about the same time each day. Tadalafil may be taken with or without food since food does not affect its absorption from the intestine.

Three Los Angeles-based companies, and five individual defendants have proffered guilty pleas on charges that they were making and distributing herbal supplements containing dangerous levels of prescription pharmaceuticals, the Department of Justice (DOJ) reports in a press release.buyaas Tadalafil powder

According to the DOJ, John Seil Lee was purchasing tadalafil powder from China and making pills he sold as herbal supplements requiring no prescription. Lee is alleged to have sold at least $11 million worth of his fake pills across the United States.

NBC Los Angeles reports that one of the companies prosecuted, Contenda Health, admitted to purchasing 1.4 million fake pills from Lee, which they then resold at retail locations all over the United States.

CVS Pharmacy is not taking any chances with misbranded or illicitly manufactured dietary supplements. According to My Healthy Click, CVS Pharmacy has begun a program called “Tested to be Trusted” on all dietary supplements in their stores. My Healthy Click reports that CVS tested over 1,400 vitamins and supplements from more than 150 brands. Seven percent of supplements tested failed the test and were pulled from shelves.

Tadalafil is an oral drug for the treatment of ED, used in the treatment of erectile dysfunction and premature ejaculation, erectile function impairment and premature ejaculation has very significant improvements. There are over 1500 documents to prove the caused by different causes impotence premature ejaculation, knew the success rate is above 80%, and show its reliable curative effect, through the use of more than 20 million people worldwide, proved its long-term stability, the safety of 25 to 60 minutes of work function to coincide with a time needed for foreplay, knew the time adjustment in the highest drug concentration time, help both husband and wife a satisfactory sex life.buyaas Tadalafil powder

Amino Tadalafil is an oral drug for the treatment of ED, used in the treatment of erectile dysfunction and premature ejaculation, erectile function impairment and premature ejaculation has very significant improvements. There are over 1500 documents to prove the caused by different causes impotence premature ejaculation, knew the success rate is above 80%, and show its reliable curative effect, through the use of more than 20 million people worldwide, proved its long-term stability, the safety of 25 to 60 minutes of work function to coincide with a time needed for foreplay, knew the time adjustment in the highest drug concentration time, help both husband and wife a satisfactory sex

S-Nitrosothiols or thionitrites with the general formula RSNO are formally composed of the nitrosyl cation (NO⁺) and a thiolate (RS⁻), the base of the corresponding acids RSH. The smallest S-nitrosothiol is HSNO and derives from hydrogen sulfide (HSH, H2S). The most common physiological S-nitrosothiols are derived from the amino acid L-cysteine (CysSH). Thus, the simplest S-nitrosothiol is S-nitroso-L-cysteine (CysSNO). CysSNO is a spontaneous potent donor of nitric oxide (NO) which activates soluble guanylyl cyclase to form cyclic guanosine monophosphate (cGMP). This activation is associated with multiple biological actions that include relaxation of smooth muscle cells and inhibition of platelet aggregation. Like NO, CysSNO is a short-lived species and occurs physiologically at concentrations around 1 nM in human blood. CysSNO can be formed from CysSH and higher oxides of NO including nitrous acid (HONO) and its anhydride (N2O3). N-Acetyl-L-cysteine ethyl ester
The most characteristic feature of RSNO is the S-transnitrosation reaction by which the NO⁺ group is reversibly transferred to another thiolate. By this way numerous RSNO can be formed such as the low-molecular-mass S-nitroso-N-acetyl-L-cysteine (SNAC) and S-nitroso-glutathione (GSNO), and the high-molecular-mass S-nitrosol-L-cysteine hemoglobin (HbCysSNO) present in erythrocytes and S-nitrosol-L-cysteine albumin (AlbCysSNO) present in plasma at concentrations of the order of 200 nM. All above mentioned RSNO exert NO-related biological activity, but they must be administered intravenously.
This important drawback can be overcome by lipophilic charge-free RSNO. Thus, we prepared the ethyl ester of SNAC, the S-nitroso-N-acetyl-L-cysteine ethyl ester (SNACET), from synthetic N-acetyl-L-cysteine ethyl ester (NACET). Both NACET and SNACET have improved pharmacological features over N-acetyl-L-cysteine (NAC) and S-nitroso-N-acetyl-L-cysteine (SNAC), respectively, including higher oral bioavailability. SNACET exerts NO-related activities which can be utilized in the urogenital tract and in the cardiovascular system. NACET has high oral bioavailability, is a strong antioxidant and abundant precursor of GSH, unlike its free acid N-acetyl-L-cysteine (NAC). Here, we review the chemical and pharmacological properties of SNACET and NACET as well as their analytical chemistry. We also report new results from the ingestion of S-[¹⁵N]nitroso-N-acetyl-L-cysteine ethyl ester (S¹⁵NACET) demonstrating the favorable pharmacological profile of SNACET.

Palmitoylethanolamide is a natural pain killer ingredient in the fatty acid amide category and synthesized within your own body, we call it endogenous. It is widely used in sports nutrition supplements and joint health formulas worldwide, especially in the United States, Australia, UK, Canada and EU countries like the Netherlands, Belgium, and Italy.

Palmitoylethanolamide is a pretty long word, if it is your first time to come across it, you may wonder how to memorize or pronounce it. Well, palmitoylethanolamide is a word consists of three words:Palmitoylethanolamide powder

In our daily life, PEA (the first letter of each of the three words) is to refer to palmitoylethanolamide for short. However, PEA itself is a plant, and PEA protein is also applied in bodybuilding supplements as a vegetarian source of protein content. Don’t get them wrong.

PEA has been demonstrated to bind to a receptor in the cell-nucleus (a nuclear receptor) and exerts a great variety of biological functions related to chronic pain and inflammation.
The IUPAC name of PEA is N-(2-Hydroxyethyl) hexadecanamide. Raw Palmitoylethanolamide is usually in the powder form, with molecule formula and weight as C18H37NO2 and 299.49 respectively. 544-31-0 is Palmitoylethanolamide’s CAS Registry Number and unique chemical identity.

Palmitoylethanolamide is practically insoluble in water and poorly soluble in most other aqueous solvents. Therefore, you may find that almost 99% fished dosage formulations of palmitoylethanolamide are in capsules or soft gels.

Palmitoylethanolamide VS Phenylethylamine
In fact, they are two completely different ingredients. No relationship is between them. Phenylethylamine or Phenylethylamine HCl is most known as a mood and weight loss ingredient in many sports nutrition. While Palmitoylethanolamide is popularly known as a painkiller. The connection is that both compounds are abbreviated as PEA, and called by PEA powder. So don’t get them wrong.

Palmitoylethanolamide vs anandamide
Many of our clients who buy bulk Palmitoylethanolamide powder are also interested in Bulk anandamide powder and anandamide oil from us. Therefore, what’s the relation between them?Both palmitoylethanolamide and anandamide are endogenous fatty acid amide in our human bodies.

According to Wikipedia, PEA and related compounds such as anandamide seem to have synergistic effects in models of pain and analgesia.Gas-chromatography/mass-spectrometry measurements indicate that the levels of anandamide and PEA in the skin are enough to cause a tonic activation of local cannabinoid receptors.

In one study, the data shows that anandamide and PEA activate pharmacologically distinct receptors and that these two substances can be produced simultaneously in tissues. When injected together in equal amounts, anandamide and PEA inhibited the early phase of formalin-evoked pain behavior with a potency that was approximately 100-fold greater than each of the compounds separately (Fig. 3a). A similar synergistic potentiation occurred in the late phase, on which anandamide had no effect when given alone (Figs 1a and 3b). Earlier administration of either CB1 or CB2 antagonists entirely blocked the response.

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential, and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways. Compound 7P
As report from Journal of medicinal chemistry shows compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, compound 7p was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo. further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.

Compound 7P basic information:

Name: Compound 7P
CAS No.:1890208-58-8
Chemical name:
2-(N-(2-methoxyphenyl)-4-methylphenylsulfonamido)-N-(4-methoxypyridin-3-yl)acetamide
2-[(2-Methoxyphenyl)[4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide
Molecular Formula: C22H23N3O5S
Molecular Weight: 441.508
Chemical Structure:

Raw Compound 7P powder which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, Raw Compound 7P powder was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of Raw Compound 7P powder translates into stimulation of axon regeneration in vivo.Compound 7P powder

Raw Compound 7P powder which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina.

In an animal model of optic nerve injury, Raw Compound 7P was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of Raw Compound 7P translates into stimulation of axon regeneration in vivo.
Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor antagonist/synthase inhibitors .

In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1) .
Raw Compound 7P (2-[(2-methoxyphenyl)[(4-methyl phenyl) sulfonyl] amino]-N-(4-methoxy-3-pyridinyl) acetamide) powder which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, Raw Compound 7P powder was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of Raw Compound 7P powder translates into stimulation of axon regeneration in vivo.further optimization of Raw Compound 7P powder and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.

Compound 7p (2-[(2-methoxyphenyl)[(4-methyl phenyl) sulfonyl] amino]-N-(4-methoxy-3-pyridinyl) acetamide) showed the highest activity against cervical cancer cells. In a nude mouse xenograft model inoculated with HeLa cells, 7p showed dose-dependent inhibition of cervical tumour growth. Histopathological examination of excised tumour-bearing tissues showed that 7p improved the microstructure in a dose-dependent manner. Compound 7p also increased the proportions of HeLa cells in G0/G1 and S-phase and significantly decreased that of G2/M-phase. The effects of 7p on C-caspase-3, C-caspase-9, Bcl-2 and Bax expression in HeLa cells were also determined.

This was the first ever study to give this novel compound to humans over a period of time,” said study senior author Professor Doug Seals, from the University of Colorado Boulder.

“We found that it is well tolerated and appears to activate some of the same key biological pathways that calorie restriction does.”For the study, the researchers included 24 lean and healthy men and women ages 55 to 79 from the Boulder area.Nicotinamide Riboside Chloride

Half were given a placebo for six weeks, then took a 500 mg twice-daily dose of NR chloride. The other half took NR for the first six weeks, followed by placebo.The team took blood samples and other physiological measurements at the end of each treatment period. Participants reported no serious adverse effects.The authors found that 1,000 mg daily of NR boosted levels of another compound called nicotinamide adenine dinucleotide (NAD+) by 60%.

NAD+ is required for activation of enzymes called sirtuins, which are largely credited with the beneficial effects of calorie restriction. It’s involved in a host of metabolic actions throughout the body, but it tends to decline with age.

“The idea is that by supplementing older adults with NR, we are not only restoring something that is lost with aging (NAD+), but we could potentially be ramping up the activity of enzymes responsible for helping protect our bodies from stress,” said first author Dr. Christopher Martens, also from the University of Colorado Boulder.

The scientists also found that in 13 participants with elevated blood pressure or stage 1 hypertension (120-139/80-89 mmHg), systolic blood pressure was about 10 points lower after supplementation. A drop of that magnitude could translate to a 25-% reduction in heart attack risk.

“If this magnitude of systolic blood pressure reduction with NR supplementation is confirmed in a larger clinical trial, such an effect could have broad biomedical implications,” they said.“Ultimately, such caloric restriction-mimicking compounds could provide an additional option — alongside the dietary changes and exercise currently recommended — for people whose blood pressure is not yet high enough to warrant medication but who are still at risk for a heart attack.”

“The study was small and ‘pilot in nature.’ We are not able to make any definitive claims that this compound is safe or going to be effective for specific segments of the population,” Dr. Martens said.